Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis

Clinical and Experimental Medicine

Volumn 8, Issue 1, 2008, Pages 1-7

  Liang, Yan ^a   Yang, Zaixing ^a   Li, Chang ^a   Zhu, Ye ^a   Zhang, Lingzhen ^a   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Chronic hepatitis B; PBC; TRAIL

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; MESSENGER RNA; PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HUMAN; IMMUNOFLUORESCENCE TEST; LEUKOCYTE; MALE; MONOCYTE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

BASE SEQUENCE; CELL MEMBRANE; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B, CHRONIC; HUMANS; LEUKOCYTES; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RNA, MESSENGER; SOLUBILITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 43449133834     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-008-0149-z     Document Type: Article

References (19)

1. Harada K, Nakanuma Y (2006) Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol 39:55-61
2. Tinmouth J, Lee M, Wanless IR et al (2002) Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22:228-234
3. Iwata M, Harada K, Kono N et al (2000) Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Hum Pathol 31:179-184
4. Harada K, Ozaki S, Gershwin ME et al (1997) Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26:1399-1405
5. Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
6. LeBlanc HN, Ashkenazi A (2003) Apo 2L/TRAIL and its death and decoy receptors. Cell Death Differ 10:66-75
7. Rus V, Zernetkina V, Puliaev R et al (2005) Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Clin Immunol 117:48-56
8. Huang Y, Erdmann N, Peng H et al (2005) The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol 2:113-122
9. Cretney E, McQualter JL, Kayagaki N et al (2005) TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 83:511-519
10. Baba N, Kobashi H, Yamamoto K et al (2006) Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray. Translational Res 148:103-113
11. Pelli N, Floreani A, Torre F et al (2007) Soluble apoptosis molecules in primary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. Clin Exp Immunol 148:85-89
12. Heathcote EJ (2000) Management of primary biliary cirrhosis. Hepatology 31:1005-1013
13. Jo M, Kim TH, Seol DW et al (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564-567
14. Higuchi H, Bronk SF, Taniai M et al (2002) Cholestasis increases tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity. J Pharmacol Exp Ther 303:461-467
15. Floreani A, Baragiotta A, Martines D et al (2000) Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment Pharmacol Ther 14:353-358
16. Janssen HL, Higuchi H, Abdulkarim A et al (2003) Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. J Hepatol 39:414-420
17. Liang X, Liu Y, Zhang Q et al (2007) Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol 178:503-510
18. Higuchi H, Bronk SF, Takikawa Y et al (2001) The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis. J Biol Chem 276:38610-38618
19. Higuchi H, Grambihler A, Canbay A et al (2004) Bile acids upregulate death receptor 5/TRAIL-receptor 2 expression via a c-jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279:51-60